F. Ajana

发表

Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.

Y. Yazdanpanah, A. Goffard, Y. Mouton, 2003, The Journal of antimicrobial chemotherapy.

Chagas Disease, France

H. Melliez, F. Lescure, G. Pialoux, 2008, Emerging infectious diseases.

Isolated cutaneous Mycobacterium avium complex infection in AIDS

C. Chidiac, É. Senneville, S. Alfandari, 1997, International journal of dermatology.

Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.

K. White, C. Orkin, C. Kityo, 2021, Journal of acquired immune deficiency syndromes.

High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients

D. Hober, D. Groote, Y. Mouton, 1996, Infection.

A Microassay for Determination of the Cytopathogenicity of Human Immunodeficiency Virus Type‐1 Isolates

D. Hober, Y. Mouton, L. Shen, 1996, Microbiology and immunology.

Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy

G. Lion, A. Chéret, F. Boufassa, 2022, AIDS.

History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic

E. Alidjinou, O. Robineau, A. Meybeck, 2021, Microorganisms.

Osteomyelitis of the wrist caused by Mycobacterium arupense in an immunocompetent patient: a unique case.

N. Veziris, É. Senneville, É. Beltrand, 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load.

Y. Yazdanpanah, H. Melliez, J. Poissy, 2012, AIDS.

Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.

D. Hober, C. Chidiac, M. Assicot, 1997, The Journal of infection.

Clinical impact of tropism testing in a real-life cohort of HIV infected patients: a retrospective observational study

P. Choisy, O. Robineau, M. Valette, 2019, BMC Infectious Diseases.

Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study

S. Scholten, B. Wynne, M. Ait-Khaled, 2021, Journal of acquired immune deficiency syndromes.

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.

Y. Yazdanpanah, G. Bahr, D. Sissoko, 2003, The Journal of antimicrobial chemotherapy.

Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues

D. Hober, E. Alidjinou, V. Canva, 2018, Journal of medical virology.

Tolerance, compliance and psychological consequences of post-exposure prophylaxis in health-care workers

É. Senneville, S. Alfandari, Y. Mouton, 1998, International journal of STD & AIDS.

Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?

Y. Yazdanpanah, H. Melliez, B. Cortet, 2011, AIDS.

ABCB1 Allele Polymorphism Is Associated with Virological Efficacy in Naïve HIV-Infected Patients on HAART Containing Nonboosted PIs But Not Boosted PIs

Y. Yazdanpanah, H. Melliez, F. Broly, 2008, HIV clinical trials.

Soluble CD23 in Human Immunodeficiency Virus Type 1 Infected Patients

D. Hober, P. Lobert, Y. Mouton, 1993, Microbiology and immunology.

[Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].

D. Sissoko, Y. Mouton, X. de la Tribonnière, 2000, Presse medicale.

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

F. Raffi, O. Launay, G. Pialoux, 2011, The Journal of infectious diseases.

Failure of intravenous antibiotic therapy of multiple temporal brain abscesses due to Propionibacterium acnes requiring temporal lobectomy.

C. Chidiac, O. Lamy, É. Senneville, 1997, The Journal of infection.

Vaccinal issues between Belgian and French travelers.

É. Senneville, P. Choisy, F. Ajana, 2012, Medecine et maladies infectieuses.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Plasma levels of sTNFR p75 and IL-8 in patients with HIV-1 infection.

D. Hober, D. de Groote, Y. Mouton, 1996, Immunology letters.

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis

J. Levron, A. Datry, J. Reynes, 1997, Antimicrobial agents and chemotherapy.

A case of immune reconstitution inflammatory syndrome related to a disseminated histoplasmosis in an HIV-1 infected patient.

H. Melliez, F. Ajana, A. Blanc, 2013, AIDS.

Personal protection against biting insects and ticks

F. Pagés, R. Migliani, J. Boutin, 2011, Parasite.

Bilateral ureteral obstruction due to Saccharomyces cerevisiae fungus balls.

C. Chidiac, É. Senneville, S. Alfandari, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation

I. Capek, V. Vaillant, A. Mailles, 2006, Epidemiology and Infection.

Haemorrhagic Ulcerative Colitis Due to Isospora Belli in AIDS

C. Chidiac, É. Senneville, S. Alfandari, 1995, International journal of STD & AIDS.

Melioidotic osteomyelitis of the femur occurring in a traveler.

Y. Yazdanpanah, É. Senneville, L. Dubreuil, 2002, Journal of travel medicine.

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.

F. Carrat, O. Launay, C. Binquet, 2016, The Journal of infectious diseases.

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.

F. Carrat, P. Sogni, G. Haour, 2015, The Lancet. Infectious diseases.

Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis.

P. Muret, L. Cotte, L. Piroth, 2019, Clinical Infectious Diseases.

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.

P. Lecocq, C. Chidiac, É. Senneville, 1993, The Journal of antimicrobial chemotherapy.

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.

Kimberly Smith, H. Crauwels, E. Overton, 2021, The lancet. HIV.

Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults

R. Walensky, K. Freedberg, Y. Yazdanpanah, 2012, AIDS.

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.

C. Katlama, L. Cuzin, J. Meynard, 2012, The Journal of antimicrobial chemotherapy.

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

J. Routy, S. De Wit, Kimberly Smith, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Natural polymorphisms in HIV‐1 protease: Impact on effectiveness of a first‐line lopinavir‐containing antiretroviral therapy regimen

P. André, Y. Yazdanpanah, L. Cotte, 2008, Journal of medical virology.

Co-trimoxazole for toxic epidermal necrolysis in AIDS

P. Lecocq, C. Chidiac, É. Senneville, 1991, The Lancet.

HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy

G. Lion, A. Chéret, F. Boufassa, 2016, AIDS.

Granulocyte‐Macrophage Colony‐Stimulating Factor and Tumor Necrosis Factor Alpha in Patients with Human Immunodeficiency Virus (HIV) Type 1 Infection

D. Hober, Y. Mouton, M. Caillaux, 1993, Microbiology and immunology.

Production of TNFα and IL‐6 by Activated Whole Blood from HIV‐1 Infected Patients Detected by a One‐Stage Procedure: Relationship with the Phenotype of HIV‐1 Isolates

D. Hober, D. de Groote, Lu Shen, 1997, Microbiology and immunology.

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.

D. Hober, E. Alidjinou, O. Robineau, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France – January 1997 to December 2006

Y. Yazdanpanah, J. Salleron, P. Bataille, 2008, Antiviral therapy.

Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

A. Fischer, R. Tubiana, L. Cravello, 2020, The Journal of antimicrobial chemotherapy.

Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations

M. Ungeheuer, O. Launay, D. Guillemot, 2009, Human vaccines.

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

A. Grzeszczuk, M. L. Jakobsen, J. Minton, 2015, PloS one.

Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial.

B. Giraudeau, J. Parienti, G. Pialoux, 2021, The Journal of antimicrobial chemotherapy.

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.

E. Alidjinou, P. Choisy, O. Robineau, 2020, AIDS patient care and STDs.

[ParaSight F in the diagnosis of Plasmodium falciparum malaria].

M. Caillaux, F. Ajana, N. Bellagra, 1998, Pathologie-biologie.

Routine drug resistance testing in proviral HIV‐1 DNA: Prevalence of stop codons and hypermutation, and associated factors

D. Hober, E. Alidjinou, O. Robineau, 2019, Journal of medical virology.

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.

P. Morlat, C. Rouzioux, L. Meyer, 2022, The Journal of antimicrobial chemotherapy.

Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.

D. Hober, E. Alidjinou, O. Robineau, 2021, Journal of Antimicrobial Chemotherapy.

A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.

A. Masquelier, C. Chidiac, Y. Mouton, 1992, The American journal of medicine.

Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series.

L. Delhaes, D. Malvy, S. Houzé, 2019, Travel medicine and infectious disease.

Acute toxoplasmosis in an immunocompetent traveller to Senegal.

É. Senneville, O. Robineau, E. Fréalle, 2018, Journal of travel medicine.

Kaposi's sarcoma in HIV-infected patients: when and how should we evaluate bone involvement?

Y. Yazdanpanah, H. Melliez, A. Cotten, 2007, AIDS.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015

B. Gazzard, A. Mocroft, A. d’Arminio Monforte, 2019, PloS one.

Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998

Y. Yazdanpanah, B. Lebouché, D. Sissoko, 2006, HIV medicine.

Lopinavir/ritonavir resistance in patients infected with HIV‐1: two divergent resistance pathways?

Y. Yazdanpanah, P. Choisy, L. Bocket, 2011, Journal of medical virology.

[Cryptococcal osteomyelitis in a patient with a lymphocytic leukemia treated with fludarabine-cyclophosphamide-rituximab].

C. Rosé, É. Senneville, L. Legout, 2013, Journal de mycologie medicale.

Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)

J. Routy, J. V. Wyk, M. Aboud, 2020 .

Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors

G. Lion, B. Cortet, C. Goujard, 2018, AIDS.

Rickettsia conorii isolated from ticks introduced to northern France by a dog

P. Lecocq, C. Chidiac, É. Senneville, 1991, The Lancet.

The effectiveness of indicator disease-based HIV testing across Europe - results from a prospective multi-centre study

M. Jakobsen, B. Gazzard, A. Mocroft, 2015 .

Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen.

Y. Yazdanpanah, C. Rabaud, Y. Mouton, 2007, AIDS.

High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients

D. Groote, F. Ajana, S. Benyoucef, 1996, Infection.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study #_#x2013; 2012 #_#x2013; 2015

A. Mocroft, J. Gatell, J. Lundgren, 2019 .

[Malarial prophylaxis with medicinal plants: toxic hepatitis due to Tinospora crispa].

N. Viget, F. Ajana, Y. Gérard, 2007, Therapie.